The Medical Treatment of Open-Angle Glaucoma

Luca Rossetti; Nicola Orzalesi; Alessandro Liberati; Harry A. Quigley

doi:10.1056/NEJM199309023291014

The Medical Treatment of Open-Angle Glaucoma

Luca Rossetti, Nicola Orzalesi, Alessandro Liberati, Harry A. Quigley

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Abstract

To the Editor: In his review of open-angle glaucoma (April 15 issue),¹ Dr. Quigley concluded that “the available data from clinical studies suggest that there is a significant reduction in the rate of initial injury when eyedrops are used to lower pressure.” We recently completed an overview of all published randomized controlled trials of the medical treatment of open-angle glaucoma,² and we disagree with this conclusion. Although a large number of such trials (n=102) have been carried out, only a few (8 of 102) have focused on the question of medical treatment for glaucoma with an appropriate study design and…

Original language	English (US)
Pages (from-to)	735-736
Number of pages	2
Journal	New England Journal of Medicine
Volume	329
Issue number	10
DOIs	https://doi.org/10.1056/NEJM199309023291014
State	Published - Sep 2 1993

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJM199309023291014

Fingerprint Dive into the research topics of 'The Medical Treatment of Open-Angle Glaucoma'. Together they form a unique fingerprint.

Cite this

@article{c30177f672ce4530bf699a1af4ed0cc4,

title = "The Medical Treatment of Open-Angle Glaucoma",

abstract = "To the Editor: In his review of open-angle glaucoma (April 15 issue),1 Dr. Quigley concluded that “the available data from clinical studies suggest that there is a significant reduction in the rate of initial injury when eyedrops are used to lower pressure.” We recently completed an overview of all published randomized controlled trials of the medical treatment of open-angle glaucoma,2 and we disagree with this conclusion. Although a large number of such trials (n=102) have been carried out, only a few (8 of 102) have focused on the question of medical treatment for glaucoma with an appropriate study design and…",

author = "Luca Rossetti and Nicola Orzalesi and Alessandro Liberati and Quigley, {Harry A.}",

year = "1993",

month = sep,

day = "2",

doi = "10.1056/NEJM199309023291014",

language = "English (US)",

volume = "329",

pages = "735--736",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - The Medical Treatment of Open-Angle Glaucoma

AU - Rossetti, Luca

AU - Orzalesi, Nicola

AU - Liberati, Alessandro

AU - Quigley, Harry A.

PY - 1993/9/2

Y1 - 1993/9/2

N2 - To the Editor: In his review of open-angle glaucoma (April 15 issue),1 Dr. Quigley concluded that “the available data from clinical studies suggest that there is a significant reduction in the rate of initial injury when eyedrops are used to lower pressure.” We recently completed an overview of all published randomized controlled trials of the medical treatment of open-angle glaucoma,2 and we disagree with this conclusion. Although a large number of such trials (n=102) have been carried out, only a few (8 of 102) have focused on the question of medical treatment for glaucoma with an appropriate study design and…

AB - To the Editor: In his review of open-angle glaucoma (April 15 issue),1 Dr. Quigley concluded that “the available data from clinical studies suggest that there is a significant reduction in the rate of initial injury when eyedrops are used to lower pressure.” We recently completed an overview of all published randomized controlled trials of the medical treatment of open-angle glaucoma,2 and we disagree with this conclusion. Although a large number of such trials (n=102) have been carried out, only a few (8 of 102) have focused on the question of medical treatment for glaucoma with an appropriate study design and…

UR - http://www.scopus.com/inward/record.url?scp=0027223886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027223886&partnerID=8YFLogxK

U2 - 10.1056/NEJM199309023291014

DO - 10.1056/NEJM199309023291014

M3 - Letter

C2 - 8345874

AN - SCOPUS:0027223886

VL - 329

SP - 735

EP - 736

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -